Skip to main content

Table 3 Univariate Analysis for recurrence-free survival (RFS) and overall survival (OS)

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

 

RFS

OS

 

HR

Conf. int.

p-value

HR

Conf. int.

p-value

Age

1.001

0.9729–1.03

0.942

1.018

0.9932–1.043

0.157

Sex

0.7161

0.3755–1.366

0.308

0.755

0.4312–1.321

0.323

Normal ECOG

0.3812

0.213–0.6823

0.002

0.333

0.2009–0.5518

< 0.001

UICC stage

1.14

0.6254–2.079

0.668

1.163

0.6781–1.996

0.582

No smoking history

0.2293

0.05573–0.9431

0.026

0.314

0.1142–0.8635

0.018

Chemotherapy

(full dose)

0.5653

0.3158–1.012

0.052

0.555

0.335–0.9195

0.021

Tumor volume

1.015

1.008–1.021

< 0.001

1.011

1.005–1.017

< 0.001

NLR

4.059

2.315–7.117

< 0.001

2.311

1.438–3.714

< 0.001